Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19984)	3/22/1999 9:32:00 PM
From: VLAD	Respond to of 23519

Anyone been following the Rezulin debate? biz.yahoo.com Looks like Warner Lambert is sweating it out and the FDA may again change the labeling or pull the drug. A special meeting to be held with the FDA as we have hit a staggering total of 35 deaths or transplants linked to the drug. So why isn't the FDA holding a special meeting with Pfizer on Viagra now that the world wide body count exceeds 430? Warner Lambert is getting scrutinized over a measley 35 deaths and the FDA acts blind to the hundreds of sildenafil associated deaths. Makes me wanna puke!